+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cerebrospinal Fluid Management Devices Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010802
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cerebrospinal Fluid Management Devices Market is projected to reach USD 1.33 Billion in 2026. It is expected to continue growing at a CAGR of 6.67%, reaching USD 1.96 Billion by 2032.

Cerebrospinal Fluid Management Devices: Executive Overview
Cerebrospinal fluid (CSF) management devices support the treatment of hydrocephalus and other disorders involving impaired CSF circulation or absorption. The field includes shunt systems, drainage products, access devices, flow-control components, and related monitoring technologies. Clinical priorities center on dependable diversion, infection prevention, obstruction reduction, pressure management, and timely intervention across pediatric, adult, trauma, oncology, and neurocritical-care settings. Adoption is shaped by neurosurgical capacity, diagnostic infrastructure, reimbursement, hospital procurement standards, and the availability of trained specialists.
Clinical Priorities Are Reshaping CSF Device Development
The landscape is shifting toward devices that improve control, reduce avoidable revisions, and support patient-specific care. Adjustable pressure systems, anti-siphon features, antimicrobial approaches, improved catheter materials, and less invasive implantation techniques address persistent complications such as infection, overdrainage, underdrainage, blockage, and mechanical failure. Hospitals are also placing greater emphasis on workflow efficiency, standardized infection-control protocols, postoperative surveillance, and lifecycle evidence rather than device acquisition alone. These changes favor products supported by rigorous clinical evaluation, interoperable monitoring, and clear training pathways.
Artificial Intelligence Strengthens Diagnosis, Monitoring, and Operational Decisions
Artificial intelligence can contribute across the CSF management pathway by assisting neuroimaging interpretation, identifying ventricular enlargement, flagging potentially abnormal pressure patterns, and prioritizing patients for specialist review. Predictive models may also help clinicians recognize patients at elevated risk of shunt malfunction or infection when combined with clinical history, imaging, laboratory results, and longitudinal device data. Practical value depends on representative datasets, external validation, transparent performance measures, cybersecurity, and integration into clinical workflows. AI should support-not replace-neurosurgical judgment, particularly when symptoms, imaging, and device behavior are discordant.
Regional Insights: Access, Infrastructure, and Specialist Capacity Differ Widely
North America benefits from established neurosurgical services, advanced imaging, and relatively broad access to specialized hospitals, while placing strong emphasis on outcomes, safety, and reimbursement evidence. Europe combines mature clinical systems with varied national procurement and regulatory pathways; the European Union’s cross-border framework can support coordination, but implementation remains country-specific. Asia-Pacific spans highly developed systems such as Japan, Australia, and South Korea alongside rapidly expanding services in China and India, creating differing needs for premium, adaptable, and cost-conscious solutions. Latin America is influenced by uneven specialist distribution, public-sector procurement, and referral-center concentration, with Brazil and Mexico serving as important clinical and manufacturing environments. The Middle East is investing in tertiary and referral care, particularly in Gulf systems, while broader regional access varies. Africa continues to face constraints in specialist availability, imaging, supply continuity, and postoperative follow-up, increasing the importance of durable devices, training, and referral networks.
Group Insights: Economic and Security Blocs Shape Procurement Context
ASEAN markets require adaptable approaches because healthcare financing, regulatory maturity, and neurosurgical capacity differ across member states. BRICS economies combine significant clinical needs with diverse public-private delivery models and local-production priorities. The European Union emphasizes coordinated standards, clinical evidence, data governance, and national-level purchasing decisions. G7 systems generally have sophisticated hospital infrastructure and demanding expectations for safety, health technology assessment, and post-market surveillance. GCC countries are strengthening tertiary-care capabilities and often prioritize advanced hospital technology, specialist partnerships, and centralized procurement. NATO members differ substantially in healthcare organization, but defense-related trauma readiness and continuity of critical-care capacity can influence planning for emergency CSF diversion and neurosurgical services.
Country Insights: National Systems Determine Clinical Adoption and Access
Australia combines concentrated specialist services with strong clinical governance and geographically dispersed referral needs. Brazil and Mexico must address regional inequality, public procurement complexity, and access outside major urban centers. Canada’s large geography makes referral coordination, supply continuity, and specialist coverage important considerations. China is expanding advanced hospital capacity while balancing regional variation and domestic innovation priorities. France, Germany, Italy, and Spain operate within established European clinical systems, but reimbursement, procurement, and hospital organization differ by country. India faces substantial unmet need alongside expanding tertiary hospitals, local manufacturing, and cost-sensitive purchasing. Japan emphasizes reliability, aging-related care needs, and rigorous clinical practice. Russia’s access conditions are shaped by domestic supply, regional distribution, and healthcare-system constraints. South Korea combines advanced hospitals, strong digital capabilities, and sophisticated clinical adoption pathways. The United Kingdom emphasizes evidence, centralized or coordinated procurement, and service resilience. The United States has extensive neurosurgical infrastructure, high demand for specialized care, and close scrutiny of clinical outcomes, device safety, and reimbursement.
Action Priorities for Leaders in CSF Device Innovation and Care Delivery
Industry leaders should prioritize designs that address the most consequential complications while demonstrating meaningful patient and workflow benefits in real-world settings. Evidence programs should include diverse age groups, care environments, revision cases, and longitudinal follow-up, with transparent reporting of infection, obstruction, overdrainage, reoperation, and usability outcomes. Organizations should build regional training and service networks, strengthen supply-chain resilience, and develop tiered solutions suited to differing hospital capabilities without compromising safety. Digital and AI features should be introduced with strong governance, clinician oversight, interoperability, cybersecurity, and post-deployment monitoring. Partnerships with neurosurgical centers, health systems, regulators, and professional societies can improve adoption by aligning product design with local protocols, procurement requirements, and workforce realities.
Research Methodology: Evidence-Based Assessment of the CSF Device Landscape
This executive summary uses a structured assessment of cerebrospinal fluid management devices across clinical use cases, technology attributes, care settings, regulatory considerations, and healthcare-system conditions. The approach integrates peer-reviewed literature, clinical guidance, regulatory materials, hospital and public-health documentation, device safety information, and regional health-system analysis. Findings are organized by region, economic or policy group, and country to distinguish consistent global themes from local constraints. Interpretation emphasizes clinically relevant outcomes, access conditions, implementation requirements, and evidence quality; unsupported commercial claims, market estimates, market sizing, market shares, and forecasts are excluded.
Conclusion: Safe, Scalable, and Evidence-Led CSF Management Is the Strategic Goal
Cerebrospinal fluid management devices remain central to care for patients whose CSF circulation is impaired, but successful treatment depends on more than device placement. Reliability, infection prevention, pressure control, specialist training, follow-up, and equitable referral pathways must advance together. Regional and national differences make adaptable implementation essential, while AI offers useful support when governed by strong clinical and data standards. Leaders that combine robust evidence, resilient delivery systems, patient-centered design, and responsible digital integration will be best positioned to improve outcomes across diverse neurosurgical environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cerebrospinal Fluid Management Devices Market, by Product Type
7.1. Introduction
7.2. Accessories
7.3. External Drainage Systems
7.4. Shunts
7.4.1. Lumboperitoneal Shunts
7.4.2. Ventriculoperitoneal Shunts
7.4.2.1. Nonprogrammable Valves
7.4.2.2. Programmable Valves
8. Cerebrospinal Fluid Management Devices Market, by Indication
8.1. Introduction
8.2. CSF Leak Repair
8.3. Hydrocephalus
8.4. Intracranial Hypertension
8.5. Intraventricular Hemorrhage
9. Cerebrospinal Fluid Management Devices Market, by Technology
9.1. Introduction
9.2. Closed Systems
9.3. Open Systems
10. Cerebrospinal Fluid Management Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Home Care Settings
10.4. Hospitals
11. Cerebrospinal Fluid Management Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Hospital Sales
11.3. Online Channels
11.4. Third Party Distributors
12. Cerebrospinal Fluid Management Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. Cerebrospinal Fluid Management Devices Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Cerebrospinal Fluid Management Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. France
14.9. Canada
14.10. Italy
14.11. Australia
14.12. South Korea
14.13. Brazil
14.14. Mexico
14.15. Russia
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Ad-Tech Medical Instrument Corporation
16.2. Aesculap AG
16.3. Becton Dickinson and Company
16.4. CereVasc, Inc.
16.5. Delta Surgical Ltd.
16.6. Dispomedica GmbH
16.7. Fuji Systems Corporation
16.8. G. Surgiwear Ltd.
16.9. Integra LifeSciences Corporation
16.10. Johnson & Johnson
16.11. Medtronic PLC
16.12. Mizuho Medical Co., Ltd.
16.13. MÖLLER Medical GmbH
16.14. Neuromedex GmbH
16.15. Nihon Kohden Corporation
16.16. Phoenix Biomedical AG
16.17. Raumedic AG
16.18. Sophysa SA
16.19. Spiegelberg GmbH & Co. KG
16.20. Stryker Corporation
16.21. VentriPoint Diagnostics Ltd.
16.22. Wellong Instruments Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cerebrospinal Fluid Management Devices Market, Years Considered for the Study
FIGURE 2. Global Cerebrospinal Fluid Management Devices Market, Research Design
FIGURE 3. Global Cerebrospinal Fluid Management Devices Market, Research Framework
FIGURE 4. Global Cerebrospinal Fluid Management Devices Market, Data Triangulation
FIGURE 5. Global Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cerebrospinal Fluid Management Devices Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Cerebrospinal Fluid Management Devices Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cerebrospinal Fluid Management Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Cerebrospinal Fluid Management Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cerebrospinal Fluid Management Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Cerebrospinal Fluid Management Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cerebrospinal Fluid Management Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Cerebrospinal Fluid Management Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cerebrospinal Fluid Management Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cerebrospinal Fluid Management Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Cerebrospinal Fluid Management Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cerebrospinal Fluid Management Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cerebrospinal Fluid Management Devices Market Segmentation & Coverage
TABLE 2. Global Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global External Drainage Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global External Drainage Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global External Drainage Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Shunts Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Shunts Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Shunts Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Lumboperitoneal Shunts Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Lumboperitoneal Shunts Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Lumboperitoneal Shunts Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Ventriculoperitoneal Shunts Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Ventriculoperitoneal Shunts Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Ventriculoperitoneal Shunts Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Nonprogrammable Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Nonprogrammable Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Nonprogrammable Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Programmable Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Programmable Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Programmable Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 26. Global CSF Leak Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global CSF Leak Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global CSF Leak Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Hydrocephalus Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Hydrocephalus Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Hydrocephalus Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Intracranial Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Intracranial Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Intracranial Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Intraventricular Hemorrhage Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intraventricular Hemorrhage Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intraventricular Hemorrhage Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 39. Global Closed Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Closed Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Closed Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Open Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Open Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Open Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 46. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. Global Direct Hospital Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Direct Hospital Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Direct Hospital Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Third Party Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Third Party Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Third Party Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Europe Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Europe Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 77. Europe Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 78. Europe Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 79. Europe Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. Europe Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Europe Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. North America Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. North America Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. North America Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 85. North America Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 86. North America Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. North America Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 88. North America Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. North America Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Latin America Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Latin America Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Latin America Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 93. Latin America Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 94. Latin America Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 95. Latin America Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. Latin America Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Latin America Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Africa Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Africa Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Africa Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 101. Africa Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 102. Africa Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. Africa Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Africa Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Africa Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Middle East Cerebrospinal Fluid Management Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Middle East Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Middle East Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 109. Middle East Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 110. Middle East Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 111. Middle East Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 112. Middle East Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Middle East Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Global Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. NATO Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. NATO Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 118. NATO Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 119. NATO Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 120. NATO Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. NATO Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. NATO Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. G7 Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. G7 Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. G7 Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 126. G7 Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 127. G7 Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 128. G7 Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. G7 Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. G7 Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. European Union Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. European Union Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 134. European Union Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 135. European Union Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 136. European Union Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. European Union Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. European Union Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. BRICS Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. BRICS Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. BRICS Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 142. BRICS Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 143. BRICS Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 144. BRICS Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. BRICS Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. BRICS Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 150. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 151. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. ASEAN Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. ASEAN Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. GCC Cerebrospinal Fluid Management Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. GCC Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. GCC Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 158. GCC Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 159. GCC Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 160. GCC Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. GCC Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. GCC Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Global Cerebrospinal Fluid Management Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. United States Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 165. United States Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. United States Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 167. United States Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 168. United States Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 169. United States Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. United States Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. United States Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. China Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 173. China Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. China Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 175. China Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 176. China Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 177. China Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. China Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. China Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Germany Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 181. Germany Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Germany Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 183. Germany Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 184. Germany Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. Germany Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. Germany Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Germany Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Japan Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 189. Japan Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Japan Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 191. Japan Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 192. Japan Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. Japan Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. Japan Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Japan Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. India Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 197. India Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. India Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 199. India Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 200. India Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. India Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. India Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. India Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. United Kingdom Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 205. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 207. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 208. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 209. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. United Kingdom Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. France Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 213. France Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. France Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 215. France Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 216. France Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 217. France Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. France Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. France Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Canada Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 221. Canada Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Canada Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 223. Canada Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 224. Canada Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 225. Canada Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Canada Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Canada Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Italy Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 229. Italy Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Italy Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 231. Italy Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 232. Italy Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 233. Italy Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 234. Italy Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Italy Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Australia Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 237. Australia Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Australia Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 239. Australia Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 240. Australia Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. Australia Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Australia Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Australia Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. South Korea Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 245. South Korea Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. South Korea Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 247. South Korea Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 248. South Korea Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 249. South Korea Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 250. South Korea Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. South Korea Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Brazil Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 253. Brazil Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Brazil Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 255. Brazil Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 256. Brazil Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 257. Brazil Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 258. Brazil Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Brazil Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Mexico Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 261. Mexico Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Mexico Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 263. Mexico Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 264. Mexico Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 265. Mexico Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Mexico Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Mexico Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Russia Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 269. Russia Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Russia Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 271. Russia Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 272. Russia Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 273. Russia Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 274. Russia Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Russia Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. Spain Cerebrospinal Fluid Management Devices Market Size, 2017-2032 (USD Million)
TABLE 277. Spain Cerebrospinal Fluid Management Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Spain Cerebrospinal Fluid Management Devices Market Size, by Shunts, 2017-2032 (USD Million)
TABLE 279. Spain Cerebrospinal Fluid Management Devices Market Size, by Ventriculoperitoneal Shunts, 2017-2032 (USD Million)
TABLE 280. Spain Cerebrospinal Fluid Management Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 281. Spain Cerebrospinal Fluid Management Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. Spain Cerebrospinal Fluid Management Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Spain Cerebrospinal Fluid Management Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Global Cerebrospinal Fluid Management Devices Market Share, by Key Player, 2025
TABLE 285. Global Cerebrospinal Fluid Management Devices Market, Key Experts

Companies Mentioned

  • Ad-Tech Medical Instrument Corporation
  • Aesculap AG
  • Becton Dickinson and Company
  • CereVasc, Inc.
  • Delta Surgical Ltd.
  • Dispomedica GmbH
  • Fuji Systems Corporation
  • G. Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Mizuho Medical Co., Ltd.
  • MÖLLER Medical GmbH
  • Neuromedex GmbH
  • Nihon Kohden Corporation
  • Phoenix Biomedical AG
  • Raumedic AG
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
  • VentriPoint Diagnostics Ltd.
  • Wellong Instruments Co., Ltd.